感染性休克
医学
重症监护医学
去甲肾上腺素
休克(循环)
重症监护
氢化可的松
败血症
免疫学
内科学
多巴胺
作者
Wagner Luís Nedel,Thiago Lisboa,Jorge I. Salluh
出处
期刊:Seminars in Respiratory and Critical Care Medicine
[Georg Thieme Verlag KG]
日期:2021-09-20
卷期号:42 (05): 726-734
被引量:5
标识
DOI:10.1055/s-0041-1733900
摘要
Corticosteroids have been used for decades in the adjunctive treatment of severe infections in intensive care. The most frequent scenario in intensive care is in septic shock, where low doses of glucocorticoids appear to restore vascular responsiveness to norepinephrine. There is a strong body of evidence suggesting that hydrocortisone reduces time on vasopressor, and may modulate the immune response. In this review, we explore the current evidence supporting the use of corticosteroids in septic shock, its benefits, and potential harms. In addition to landmark clinical trials, we will also describe new frontiers for the use of corticosteroids in septic shock which should be explored in future studies.
科研通智能强力驱动
Strongly Powered by AbleSci AI